gene expression omnibus public genomic data repository (Biotechnology Information)
86
Structured Review
Biotechnology Information
gene expression omnibus public genomic data repository
Gene Expression Omnibus Public Genomic Data Repository, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+data/expression+gene+omnibus+%E2%80%A2/pm42297033-150-18-16
Average 86 stars, based on 1 article reviews
Gene Expression Omnibus Public Genomic Data Repository, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+expression+data/expression+gene+omnibus+%E2%80%A2/pm42297033-150-18-16
Average 86 stars, based on 1 article reviews
gene expression omnibus public genomic data repository - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Gene Expression:Article Title: Synovial transcriptomic biomarkers predict structural severity in equine osteochondral fragment-induced experimental osteoarthritis. Article Snippet: .. The names of the repository and accession number can be found at the National Center for Biotechnology Information Article Title: Single-cell RNA sequencing profiles drug activity within spatially engineered 3D cultures. Article Snippet: .. The scRNA-seq datasets generated in this study have been deposited in the National Centre for Biotechnology Information ( Article Title: Cepharanthine suppresses lung adenocarcinoma through targeting glutathione peroxidase 4 Article Snippet: .. Microarray datasets pertinent to LUAD were sourced from the Article Title: APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC Article Snippet: .. RNA sequencing data that support the findings of this study have been deposited in the National Center for Biotechnology Information (NCBI)'s Article Title: A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial. Article Snippet: .. Expression data will be available in the National Center for Biotechnology Information Generated:Article Title: Single-cell RNA sequencing profiles drug activity within spatially engineered 3D cultures. Article Snippet: .. The scRNA-seq datasets generated in this study have been deposited in the National Centre for Biotechnology Information ( Microarray:Article Title: Cepharanthine suppresses lung adenocarcinoma through targeting glutathione peroxidase 4 Article Snippet: .. Microarray datasets pertinent to LUAD were sourced from the Article Title: Quercetin Affects Carcinogenic Phenotype of Breast and Lung Cancer Cells Differentially Through Sterol Regulation Mediated by MALAT1 Perturbation. Article Snippet: Targeting MALAT1 in cancer treatment is an attractive strategy due to the undebatable role of this lncRNA in the disease.. Small molecules toward this noncoding RNA have, in fact, entered preclinical trials, without resulting in a robust demonstration in favor of their use in therapy.. To test the robustness of this method, we asked how aspects of carcinogenesis get affected when knocking down MALAT1 in different cell lines. RNA Sequencing:Article Title: APE1 inhibition-promoted pyroptosis triggers T-cell infiltration and enhances anti-tumor immunity in NSCLC Article Snippet: .. RNA sequencing data that support the findings of this study have been deposited in the National Center for Biotechnology Information (NCBI)'s Article Title: Quercetin Affects Carcinogenic Phenotype of Breast and Lung Cancer Cells Differentially Through Sterol Regulation Mediated by MALAT1 Perturbation. Article Snippet: Targeting MALAT1 in cancer treatment is an attractive strategy due to the undebatable role of this lncRNA in the disease.. Small molecules toward this noncoding RNA have, in fact, entered preclinical trials, without resulting in a robust demonstration in favor of their use in therapy.. To test the robustness of this method, we asked how aspects of carcinogenesis get affected when knocking down MALAT1 in different cell lines. Expressing:Article Title: Quercetin Affects Carcinogenic Phenotype of Breast and Lung Cancer Cells Differentially Through Sterol Regulation Mediated by MALAT1 Perturbation. Article Snippet: Targeting MALAT1 in cancer treatment is an attractive strategy due to the undebatable role of this lncRNA in the disease.. Small molecules toward this noncoding RNA have, in fact, entered preclinical trials, without resulting in a robust demonstration in favor of their use in therapy.. To test the robustness of this method, we asked how aspects of carcinogenesis get affected when knocking down MALAT1 in different cell lines. Article Title: A Phase Ib Trial of Copanlisib in Combination with Venetoclax in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma-SAKK 66/18 Trial. Article Snippet: .. Expression data will be available in the National Center for Biotechnology Information |
![(A) Cohen’s h values for pairwise comparisons between 𝒞 and the other two groups: ℬ and ℐ . Primate <t>Specific</t> Ratios are calculated as in . A higher absolute Cohen’s h indicates a greater difference in ratios between the two compared groups. Green bar represents ℬ , orange bar represents ℐ , and blue bars represent 𝒞 . (B) Results of Fisher’s exact tests for pairwise comparisons between each of ℬ , ℐ , and 𝒞 and each control group ( ℱ and ℛ ), together with the comparison between ℱ and ℛ . Primate Specific Ratios are calculated as in . Statistical significance is denoted by asterisks. Results with p-values less than 0.01 are indicated by two asterisks (**), results with p-values less than 0.05 are indicated by one asterisk (*), and all other results are marked as ns . Green bar represents ℬ , orange bar represents ℐ , blue bar represents 𝒞 , gray bars represent ℛ , and purple bars represent ℱ . (C) The number of tissues corresponding to each quantile for the brain <t>genes</t> and immune-related genes. Green bars represent ℬ , orange bars represent ℐ , and gray bars represent all genes that have at least one highly expressed <t>tissue</t> in Human Protein Atlas [ , ]. (D) The number and ratio of genes highly expressed specifically in brain tissues or immune-related tissues, out of 1019 brain genes and 586 immune-related genes, respectively.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0339/pmc13160339/pmc13160339__pone.0348713.e089.jpg)